Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

M2 Receptor Measurements in Aging and in Alzheimer's Disease

Authors not listed

National Institute of Mental Health (NIMH) · 1999

Abstract

The purpose of this study is to use brain imaging technology to study the effects of aging and Alzheimer's Disease (AD) on a specific type of brain receptor. The brain is made up of cells called neurons. The neurons communicate with one another and secrete chemicals called neurotransmitters. The neurotransmitters bind to specific sites on other neurons called receptors. Acetylcholine (ACh) is a neurotransmitter that binds to ACh receptors. In both aging and AD, the number of neurons that secrete ACh decreases and the function of some ACh receptors changes. This study will use positron emission tomography (PET) scans of the brain to study the effects of age and AD on muscarinic type 2 \[M2\], a type of ACh receptor. Participants in this study will be injected with a radioactive tracer (ligand \[F-18\] FP-TZTP) which binds to \[M2\] receptors. Participants will then undergo a PET scan in order for the density and function of \[M2\] receptors to be studied.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-05-31 MST

Cite this

APA
Anonymous. (1999). M2 Receptor Measurements in Aging and in Alzheimer's Disease. <em>National Institute of Mental Health (NIMH)</em>. https://clinicaltrials.gov/study/NCT00001917
Vancouver
Anonymous. M2 Receptor Measurements in Aging and in Alzheimer's Disease. National Institute of Mental Health (NIMH). 1999.
BibTeX
@misc{anon1999MRecep, title = {M2 Receptor Measurements in Aging and in Alzheimer's Disease}, author = {Anonymous}, journal = {National Institute of Mental Health (NIMH)}, year = {1999}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings